How Decentralized & Community-Based Solutions Can Drive Change In Women's Healthcare

Are more women affected by the condition than men? If the answer is 'yes', then this truth should be reflected in the trial data. Clinical trials need to be designed around the population the therapy ultimately aims to treat. To do this, barriers to participation must be reduced or removed wherever possible. See how bringing trials to patients, where they are, increases participation as well as improves real-world data by reaching those patients who ordinarily wouldn't be able to participate in clinical trials.